SCHEMBL12879928

SCHEMBL12879928

CC(C)(C)c1cc(C(=O)Cc2cc(C(=O)c3cc(C(C)(C)C)cc(C(C)(C)C)c3)cc(C3(c4cc(C(=O)c5cc(C(C)(C)C)cc(C(C)(C)C)c5)cc(C(=O)c5cc(C(C)(C)C)cc(C(C)(C)C)c5)c4)c4ccccc4-c4ccccc43)c2)cc(C(C)(C)C)c1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP26A1 O43174 1/20 0.35
▸ CYP26B1 Q9NR63 1/20 0.35
▸ ACHE P22303 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ RXRA P19793 1/20 0.32
▸ RXRB P28702 1/20 0.32
▸ RXRG P48443 1/20 0.32
▸ PDK2 Q15119 4/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ SRD5A2 P31213 1/20 0.32
▸ TP53 P04637 1/20 0.31
▸ MDM2 Q00987 1/20 0.31
▸ NR1H4 Q96RI1 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ RECQL P46063 1/20 0.30
▸ EGFR P00533 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12864228 0.88 ESR1 (0.40) ACHEESR1ESR2RXRARXRB
SCHEMBL12864216 0.80 SRD5A2 (0.47) ESR1ESR2PDK2RAB9ALMNA
SCHEMBL2606070 0.74 SRD5A2 (0.41) ESR1ESR2PDK2RAB9ALMNA
SCHEMBL25789452 0.72 PDK2 (0.41) ESR1ESR2PDK2LMNAALDH1A1
SCHEMBL1167840 0.72 TDP1 (0.52) ESR1ESR2PDK2RAB9ALMNA
SCHEMBL12801046 0.72 RXRA (0.46) CYP26A1CYP26B1ACHERXRARXRB
SCHEMBL12864215 0.71 ESR1 (0.46) ESR1ESR2PDK2LMNAALDH1A1
SCHEMBL2605984 0.70 ALDH1A1 (0.48) ESR1ESR2PDK2RAB9ALMNA
SCHEMBL12864223 0.69 CNR1 (0.41) ESR1ESR2PDK2LMNA
SCHEMBL12864217 0.68 POLB (0.47) ESR1ESR2PDK2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8361638-B2 Fluorine derivatives for organic electroluminescence devices MERCK PATENT GMBH (DE) 2013-01-29 — — US disclosed
US-20110037027-A1 FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2011-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110037027-A1 FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES SLCO4C1, CTCF, AFF2 CYP26A1 1839/4885CYP26B1 1758/4885ACHE 928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback